Sun Pharma registers adjusted net profit of Rs 3219.6 Cr in Q3FY25

Q3 Gross Sales at Rs 134,369 million up 10.5 per cent YoY Sun Pharmaceutical Industries reported financials for the third quarter ending December 31, 2024. Highlights of Q3FY25 consolidated financials* · Gross sales at Rs 134,369 million, growth of 10.5 per cent · India formulation